Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
Millar BC, Bell JB, Montes A, Millar JL, Maitland JA, Treleaven J, Viner C, Gore M, McElwain TJ. Millar BC, et al. Among authors: treleaven j. Br J Haematol. 1990 Jul;75(3):366-72. doi: 10.1111/j.1365-2141.1990.tb04350.x. Br J Haematol. 1990. PMID: 2201402
Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisolone.
Bell JB, Millar BC, Montes-Borinaga A, Joffe JK, Cunningham D, Mansi J, Treleaven J, Viner C, McElwain TJ. Bell JB, et al. Among authors: treleaven j. Hematol Oncol. 1990 Nov-Dec;8(6):347-53. doi: 10.1002/hon.2900080607. Hematol Oncol. 1990. PMID: 2286358 Clinical Trial.
351 results